Monthly Archives: June 2023

04Jun/23

PROTAC is Moving Towards Clinical Application of Oncology—II

June 4, 2023protac reviewsAR PROTAC, BTK PROTAC, ER protacbiolabs

Preclinical evidence of PROTAC The breakthrough in PROTAC’s design paves the way for its early clinical trials. According to statistics, as of January 8, 2023, 18 kinds of PROTAC were conducting phaseRead More…

04Jun/23

PROTAC is Moving Towards Clinical Application of Oncology—I

June 4, 2023protac reviewsprotac, Protein targeted degradationbiolabs

PROTAC uses the natural mechanism of protein degradation in cells, that is, the ubiquitin-protease system, to induce targeted protein degradation. Compared with traditional small molecular inhibitors used in cancer therapy, PROTAC hasRead More…

PROTAC Research
PROTAC News